In tumor infiltrating immune cells, the risk score was negatively correlated with tumor-infiltration lymphocytes (TILs) (including CD4 + T cells, NK, and CD8 + T cells), which played an important role in immunotherapy [62–64]. Here, CD8A is linked to neoplasm.